• Jürgen Sautter, Ole F Olesen, Jeremy Bray, and Ruxandra Draghia-Akli.
• Directorate Health, Directorate-General of Research, European Commission, CDMA 2/187, B-1049 Brussels, Belgium.
• Vaccine. 2011 Sep 9; 29 (39): 6723-7.

AbstractRecent developments in vaccine research provide new momentum for an important area in health innovation. Particularly interesting are novel DNA vaccine approaches, many of which are already under clinical investigation. The Framework Programmes of the European Union play an important role in supporting collaborative efforts in vaccine research to develop new and better vaccines and bring them to the market. With a timely strategic reorientation towards a sustainable investment in innovation, the current seventh Framework Programme will help to bring large industry and small and medium-sized enterprises (SME) on board and foster partnership between stakeholders. As the first human DNA vaccines progresses through the development pipeline, more and more questions revolve around licensing and regulation and appropriate guidelines are being developed.Copyright © 2011. Published by Elsevier Ltd.

22 keywords...

hide…